Abstract
Business interests increasingly call the shots in medical education and research. Such a trend is surprising, because medical education and research are costly, offer delayed results, and, ideally, benefit all—hardly, it would seem, the venue for profiteering.This article can also be found at the Monthly Review website, where most recent articles are published in full.Click here to purchase a PDF version of this article at the Monthly Review website.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
